Skip to main content
. 2018 Sep 5;10(4):220–229. doi: 10.15171/mejdd.2018.114

Table 1. Patients’ Demographic Data .

Patients’ characteristics Group 1 (n = 16) Group 2 (n = 11) Group 3 (n = 4) P value
Age 49.7 ± 11 28.8 ± 12.2 45.0 ± 13.6 0.54
Sex M = 14, F = 2 M = 8, F = 3 M = 3, F = 1 0.400
Type of IBD UC = 11 UC = 6 UC = 3 0.01
CD = 2 CD = 2 CD = 1
IC = 3 IC = 3 IC = 0
Extend of disease Pancolitis = 4 Pancolitis = 2 Pancolitis = 0 0.52
Left sided = 7 Left sided = 5 Left sided = 2
Proctitis = 2 Proctitis = 2 Proctitis = 1
Colonic CD = 1 Colonic CD = 1 Colonic CD = 0
Ileal = 0 Ileal = 0 Ileal = 0
Ileo-colonic = 2 Ileo-colonic = 1 Ileo-colonic = 1
Duration of disease Mean = 13 yrs. Mean = 11 yrs. Mean = 9 yrs. 0.008
Hospital admission 16 11 4 0.06
Steroids 16 11 4 0.60
Thiopurine 8 5 3 0.54
Antibiotics 4 1 3 0.24
Anti TNF 6 1 1 1.00
5 ASA 12 9 3 0.200
Cyclosporine 3 0 1 1.00
Positive serology 14 9 4 0.001
Previous surgery 5 2 1 0.600
Positive cytopathic changes on HE 13 8 3 0.46
Colectomy
(three patients with UC had colectomy without treatment with ganciclovir and were excluded)
1 3 1 0.190
Death 0 1 0 1.00
Transfusion reaction 3 0 1 1.00
Side effect 3 1 1 0.88
UC- ulcerative colitis, CD- Crohn’s disease, IC- Indeterminate colitis, TNF- tumor necrotic factor, ASA- aminosalicylic acid